echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Heavy! Union Medical College Hospital Releases "New Crown Diagnosis and Treatment Reference Plan"

    Heavy! Union Medical College Hospital Releases "New Crown Diagnosis and Treatment Reference Plan"

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For medical professionals only



    Diagnose and treat big and small problems, see what the guidelines say


     

    In order to enhance physicians' understanding of the novel coronavirus infection and its critical diseases, provide a basis for clinical decision-making, promote standardized diagnosis and treatment, and improve the level of patient treatment, Peking Union Medical College Hospital issued the "Reference Plan for the Diagnosis and Treatment of New Coronary Pneumonia in the Department of Respiratory and Critical Care Medicine (December 2022 Edition)
    ".

    The relevant points of the small medicine interception are as follows
    .

    How to judge severe and critical illness of the new crown?


    Image source "Clinical Decision Assistant App", welcome to download, come to the clinical guideline function search, get the original text of the guide

    Which outpatients should be considered for antiviral therapy?


    Image source "Clinical Decision Assistant App", welcome to download, come to the clinical guideline function search, get the original text of the guide

    How can nematevir/ritonavir be used appropriately?


    Image source "Clinical Decision Assistant App", welcome to download, come to the clinical guideline function search, get the original text of the guide

    Management of hospitalized patients with novel coronavirus infection


    Image source "Clinical Decision Assistant App", welcome to download, come to the clinical guideline function search, get the original text
    of the guideSource: How to interpret the Ct value of nucleic acid detection in the "Reference Plan for the Diagnosis and Treatment of New Coronary Pneumonia in the Department of Respiratory and Critical Care Medicine of Peking Union Medical College Hospital (December 2022 Edition)
    "? How to understand the problem of re-positive and reinfection? What are the precautions when pregnant with new coronavirus infection? How can patients and medical staff be protected?
    Want to get the original guide? Download more free guides?
    Open the Clinical Decision Assistant App Clinical Guidelines Module ↓↓↓
    References: [1] Therapeutics and COVID-19:living guideline,16 September 2022.
    [2]National Institutes of Health.
    Coronavirus disease 2019(COVID-19)treatment guidelines.
    https://covid19treatmentguidelines.
    nih.
    gov/.
    [3] Diagnosis and treatment protocol for novel coronavirus pneumonia (trial 9th edition).
    style="font-size: 13px;color: rgb(136, 136, 136);" _mstmutation="1" _istranslated="1">15/5679257/files/49854a49c7004f4ea9e622f3f2c568d8.
    pdf
    [4]COVID-19:Evaluation of adults with acute illness in the outpatient setting.
    covid-19-evaluation-of-adults-with-acute-illness-in-the-outpatientsetting?search=%E6%96%B0%E5%86%A0%E9%97%A8%E8%AF%8A&source=search_result&selectedTitle=1~
    150&usage_type=default&display_rank=1.
    [5]COVID-19:Management in hospitalized adults.
    A2&source=Out%20of%20date%20-%20zhHans&selectedTitle=1~150.
    [6]RECOVERY Collaborative Group,Horby P,Lim WS,et al.
    Dexamethasone in hospitalized patients with COVID19.
    N Engl J Med 2021; 384:693-704.
    [7]REMAP-CAP Investigators,Gordon AC,Mouncey PR,et al.
    Interleukin-6 receptor antagonists in critically ill
    patients with COVID-19.
    N Engl J Med 2021; 384:1491-502.
    [8]Guimaraes PO,Quirk D,Furtado RH,et al.
    Tofacitinib in patients hospitalized with COVID-19 pneumonia.
    N Engl
    J Med 2021; 385:406-15.


    Click "Read Original" for the full guide

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.